1. Home
  2. VRTX vs NOW Comparison

VRTX vs NOW Comparison

Compare VRTX & NOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vertex Pharmaceuticals Incorporated

VRTX

Vertex Pharmaceuticals Incorporated

N/A

Current Price

$554.62

Market Cap

123.4B

Sector

Technology

ML Signal

N/A

Logo ServiceNow Inc.

NOW

ServiceNow Inc.

HOLD

Current Price

$127.26

Market Cap

132.8B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRTX
NOW
Founded
1989
2004
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Computer Software: Prepackaged Software
Sector
Technology
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
123.4B
132.8B
IPO Year
2006
2012

Fundamental Metrics

Financial Performance
Metric
VRTX
NOW
Price
$554.62
$127.26
Analyst Decision
Buy
Strong Buy
Analyst Count
29
32
Target Price
$539.69
$185.45
AVG Volume (30 Days)
1.2M
18.9M
Earning Date
05-04-2026
04-22-2026
Dividend Yield
N/A
N/A
EPS Growth
836.54
N/A
EPS
8.33
0.74
Revenue
$2,488,652,000.00
$1,933,026,000.00
Revenue This Year
$10.79
$21.55
Revenue Next Year
$10.47
$18.38
P/E Ratio
$65.74
$173.10
Revenue Growth
46.20
39.02
52 Week Low
$374.17
$81.24
52 Week High
$555.32
$973.63

Technical Indicators

Market Signals
Indicator
VRTX
NOW
Relative Strength Index (RSI) 67.74 60.13
Support Level $458.05 $123.78
Resistance Level N/A $137.92
Average True Range (ATR) 13.77 5.10
MACD 3.82 0.11
Stochastic Oscillator 93.74 77.55

Price Performance

Historical Comparison
VRTX
NOW

About VRTX Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio, and Alyftrek for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex has diversified its portfolio through Casgevy, a gene-editing therapy for beta thalassemia and sickle-cell disease, and Journavx, a non-opioid pain medication approved for the treatment of moderate-to-severe acute pain in adults. Additionally, Vertex is evaluating small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.

About NOW ServiceNow Inc.

ServiceNow Inc provides software solutions to structure and automate various business processes via a SaaS delivery model. The company primarily focuses on the IT function for enterprise customers. ServiceNow began with IT service management, expanded within the IT function, and more recently directed its workflow automation logic to functional areas beyond IT, notably customer service, HR service delivery, and security operations. ServiceNow also offers an application development platform as a service.

Share on Social Networks: